AstraZeneca hails ‘milestone’ US approval for lung cancer drug via @FT
https://t.co/38beqPm76b— The Propell Group (@ThePropellGroup) February 20, 2018
AstraZeneca hails ‘milestone’ US approval for lung cancer drug via @FT
https://t.co/38beqPm76b— The Propell Group (@ThePropellGroup) February 20, 2018